La Jolla-based Regulus Therapeutics', which is developing microRNA therapeutics in the oncology, fibrosis, hepatitis C and metabolic diseases areas, said yesterday that it has named Victor Knopov as its Vice President, Pharmaceutical Development. Knopov previously was at Nitto Denk Technical Corporation. He also served at Diversified Bio-Medics, EnGene, Marina Biotech, and Inex Pharmaceuticals.
Top NewsWednesday, November 28, 2012
Regulus Therapeutics Names VP